0001437749-25-029104.txt : 20250915 0001437749-25-029104.hdr.sgml : 20250915 20250915210938 ACCESSION NUMBER: 0001437749-25-029104 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250911 FILED AS OF DATE: 20250915 DATE AS OF CHANGE: 20250915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: UECKER DARRIN CENTRAL INDEX KEY: 0001276311 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 251315557 MAIL ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PULSE BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 465696597 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 510-906-4600 MAIL ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: Pulse Biosciences, Inc. DATE OF NAME CHANGE: 20151210 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 4 1 rdgdoc.xml FORM 4 X0508 4 2025-09-11 0001625101 PULSE BIOSCIENCES, INC. PLSE 0001276311 UECKER DARRIN C/O PULSE BIOSCIENCES, INC. 3957 POINT EDEN WAY HAYWARD CA 94545 1 1 Chief Technology Officer 1 Common Stock 2025-09-11 4 M 0 25000 4 A 147872 D Common Stock 2025-09-11 4 S 0 25000 14.78 D 122872 D Common Stock 2025-09-12 4 M 0 25000 4 A 147872 D Common Stock 2025-09-12 4 S 0 25000 14.32 D 122872 D Common Stock 2025-09-15 4 M 0 25000 4 A 147872 D Common Stock 2025-09-15 4 S 0 25000 15.77 D 122872 D Stock Option (right to buy) 4 2025-09-11 4 M 0 25000 0 D 2019-09-08 2025-09-20 Common Stock 25000 156534 D Stock Option (right to buy) 4 2025-09-12 4 M 0 25000 0 D 2019-09-08 2025-09-20 Common Stock 25000 131534 D Stock Option (right to buy) 4 2025-09-15 4 M 0 25000 0 D 2019-09-08 2025-09-20 Common Stock 25000 106534 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025. The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $14.41 to $15.14 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $13.80 to $14.76 per share. The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $15.18 to $17.20 per share. Options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015. /s/ Kenneth B. Stratton, as Attorney-in-Fact 2025-09-15